Dr. Oded Ben-Joseph, Managing Director, has recently published an article in Nature Biotechnology’s August 2016 issue, “Where the Bodies Lie,” about avoiding common mistakes made in life sciences startups.
Where the Bodies Lie. Nature Biotechnology 34, 909–911 (2016) doi:10.1038/nbt.3660
“As members of a life sciences advisory and investment banking group, my partners and I have often noted that life sciences companies fall victim to the same mistakes and misconceptions, repeated again and again. These failures mostly hinge upon company management misunderstanding the fundamentals of market dynamics and failing to appreciate the importance of the exit—the sole event where company investors receive a return on their investment, either through an initial public offering (IPO) or a company sale…..” Read full article
Please contact mhawlik@outcomecapital.com for more information.
BOSTON– February 26, 2025 – Outcome Capital, LLC, a highly specialized life sciences and healthcare advisory and investment banking firm, congratulates RealizedCare on the success of their company, and acquisition by XRHealth. Outcome Capital served as the exclusive strategic and financial advisor to RealizedCare. Through their digitally-powered care management triage platform and therapeutic solutions, RealizedCare […]
Read MoreOutcome Capital Life Science Market Pulse February 2025 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?